CRT 2026

EVENING SYMPOSIUM | CRT-SCAI JOINT SESSION | INTERVENTIONAL CARDOLOGY FELLOWSHIP PROGRAM DIRECTOR'S SUMMIT [ROUNDTABLE PARTICIPANTS]

Roundtable Participant(s)

• 

  Tayo A. Addo, MD

  Professor
  The University of Texas Southwestern Medical Center
  DALLAS, Texas, United States

  Disclosure(s): No financial relationships to disclose
• 

  Amit Amin, MD

  Associate Professor of Medicine
  Rush University Medical Center
  Chicago, Illinois, United States

  Disclosure information not submitted.
• 

  Usman Baber, MD, MS

  Professor of Medicine
  University of Oklahoma Health Sciences Center
  Oklahoma City, Oklahoma, United States

  Disclosure information not submitted.
• 

  Konstantinos Dean Boudoulas, MD

  Professor of Medicine; Section Head, Interventional Cardiology; Director, Cardiac Catheterization Laboratories
  The Ohio State University
  Columbus, Ohio, United States

  Disclosure(s): No financial relationships to disclose
• 

  Joaquin E. Cigarroa, MD

  Director, Knight Cardiovascular Institute
  OHSU Knight Cardiovascular Institute
  Portland, Oregon, United States

  Disclosure(s): No financial relationships to disclose
• 

  Tim A. Fischell, MD, FACC, MSCAI

  Director of Cardiovascular Research
  Borgesd Heart Institute
  Kalamazoo, Michigan, United States

  Disclosure(s): Balosmark, Inc.: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing); VivaCath, Inc.: Owner/Co-Owner Founder/Co-Founder (Ongoing), Stock-privately held company (Ongoing)
• 

  David L. Fischman, MD

  Director, Intervention Fellowship Program. Co-Director Cardiac Cath Lab
  Thomas Jefferson University Hospital
  Mount Laurel, New Jersey, United States

  Disclosure(s): No financial relationships to disclose
• 

  Rani K. Hasan, MD, MHS

  Assistant Professor of Medicine
  Johns Hopkins University, Maryland, United States

  Disclosure(s): SSVP HRT LLC: Stock-privately held company (Ongoing)
• 

  James B. Hermiller, MD, FACC, MSCAI

  Director Interventional Cardiology
  St. Vincent Medical Group
  Indianapolis, Indiana, United States

  Disclosure(s): Edwards, Abbott: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Anand Irimpen, MD, FACC, FSCAI

  Professor of Medicine
  Tulane University

  Disclosure(s): No financial relationships to disclose
• 

  Vijay Iyer, MD, PhD

  Associate Professor
  University at Buffalo
  East Amherst, New York, United States

  Disclosure information not submitted.
• 

  Schuyler Jones, MD

  Professor of Medicine
  Duke University Health System
  Durham, North Carolina, United States

  Disclosure(s): Merck Pharmaceuticals: Grant/Research Support (Ongoing); Novartis Pharmaceuticals: Grant/Research Support (Ongoing)
• 

  Neal S. Kleiman, MD, FACC, MSCAI

  Medical Director, Cardiac Catheterization Laboratories
  Houston Methodist DeBakey Heart and Vascular Center
  Houston, Texas, United States

  Disclosure information not submitted.
• 

  Rony Lahoud, MD

  Associate Professor
  University of Vermont
  S. Burlington, Vermont, United States

  Disclosure(s): Abbott Vascular, Medtronic, Boston Scientific: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Ablative Solutions, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Edwards Lifesciences LLC: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
• DL

  David P. Lee, MD

  Professor of Medicine
  Stanford University
  Stanford, California, United States

  Disclosure information not submitted.
• 

  Ramesh Mazhari, MD, MBA

  Professor of Medicine, Director of Cardiovascular ICU
  George Washington University, District of Columbia, United States

  Disclosure(s): No financial relationships to disclose
• 

  Bibhu D. Mohanty, MD

  Associate Professor of Medicine
  University of South Florida / Tampa General Hospital

  Disclosure(s): Edwards Life Sciences: Grant/Research Support (Ongoing); J&J Med Tech/Abiomed: Grant/Research Support (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing)
• 

  Srini Potluri, MD

  Chief of Cardiology
  Baylor Scott and White The Heart Hospital Plano
  Frisco, Texas, United States

  Disclosure information not submitted.
• 

  Vinoy S. Prasad, MD, FACC, FSCAI

  Director of Interventional Cardiology
  Loma Linda University Medical Center
  Redlands, California, United States

  Disclosure(s): No financial relationships to disclose
• 

  Michael Ragosta, MD

  Interventional Cardiologist
  University of Virginia
  Charlottesville, Virginia, United States

  Disclosure(s): No financial relationships to disclose
• 

  David G. Rizik, MD, MSCAI, FACC

  Health System Chief of Cardiovascular Service Line, Physician Executive Community Cardiovascular Research
  Banner University Medicine, Scottsdale Arizona
  Scottsdale, Arizona, United States

  Disclosure(s): No financial relationships to disclose
• 

  Scott W. Shurmur, MD

  Chair, Internal Medicine; Interventional PD
  Texas Tech Health Sciences Center, Lubbock
  Lubbock, Texas, United States

  Disclosure(s): No financial relationships to disclose
• 

  Joseph L. Thomas, MD

  Chair, Department of Medicine
  Harbor UCLA Medical Center
  TORRANCE, California, United States

  Disclosure(s): Holistick Medical, Intershunt, Intervene, K2, Laminar, Lifetech, Magenta, Maquet Getinge Group, Metavention, Mitralix, Mokita, Myotec, Neurotronic, Novelrad, NXT Biomedical, Occlutech, Recor: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)